QTX3034 in Patients With KRAS G12D Mutation
Clinical trial NCT06227377 · RECRUITING
Trial details
- NCT number
- NCT06227377
- Sponsor
- Quanta Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-05
- Primary completion
- 2027-04-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.